Bleomycin-induced lung fibrosis: The authors should have used another method to induce pulmonary lesions resembling human idiopathic pulmonary fibrosis

被引：21

作者：

Gabazza, EC ^{[1
]}

Taguchi, O ^{[1
]}

Adachi, Y ^{[1
]}

机构：

[1] Mie Univ, Sch Med, Tsu, Mie, Japan

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2002年 / 165卷 / 06期

关键词：

D O I：

10.1164/ajrccm.165.6.correspondence_c

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：845 / 846

页数：2

共 5 条

[1] Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis [J].

Borzone, G ;

Moreno, R ;

Urrea, R ;

Meneses, M ;

Oyarzún, M ;

Lisboa, C .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (07) :1648-1653

[2]

HARRISON JH, 1987, J PHARMACOL EXP THER, V243, P1185

[3] Idiopathic pulmonary fibrosis - Clinical relevance of pathologic classification [J].

Katzenstein, ALA ;

Myers, JL .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) :1301-1315

[4]

Myers JL, 1997, KATZENSTEIN ASKINS S, V13, P81

[5] Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse [J].

Yasui, H ;

Gabazza, EC ;

Tamaki, S ;

Kobayashi, T ;

Hataji, O ;

Yuda, H ;

Shimizu, S ;

Suzuki, K ;

Adachi, Y ;

Taguchi, O .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (07) :1660-1668

← 1 →